Table 2– Computed tomography derived abdominal fat areas and blood lipid data in sleep apnoea patients versus controls at baseline stratified by sex

	Males			Females^#
	Controls	Apnoeics	p-value	Controls	Apnoeics	p-value
Subjects n	19	22		20	20
VAT cm²
L1	114.67±13.84	176.29±14.88	<0.01	78.62±9.68	101.50±9.42	0.11
L2	145.5±14.99	191.24±9.03	0.04	103.16±9.91	109.30±9.65	0.67
L3	130.95±13.22	184.12±12.37	0.01	101.24±10.67	116.10±10.38	0.34
L4	114.95±11.03	150.81±8.55	0.02	109.55±9.87	121.09±9.60	0.42
L5	91.17±5.96	114.90±6.32	0.02	96.99±8.12	109.90±7.90	0.28
Total VAT cm²	597.270±57.24	799.382± 46.99	0.01	497.79±40.83	560.31±40.83	0.30
SAT cm²
L1	112.23±10.68	100.4±6.20	0.33	168.47±10.77	199.12±10.48	0.06
L2	145.91±14.99	125.77±9.03	0.24	208.96±11.25	245.37±10.95	0.03
L3	185.39±16.87	163.27±10.89	0.25	283.04±14.04	287.79±13.66	0.02
L4	222.79±17.81	200.09±12.69	0.29	296.41±17.98	336.98±17.49	0.13
L5	218.21±15.81	207.88±14.17	0.64	365.74±17.18	399.74±16.72	0.18
Total SAT cm²	884.55±72.69	768.72±51.13	0.20	1274.71±59.11	1476.24±59.11	0.02
Total (VAT+SAT) cm²	1481.82±106.92	1568.10±87.66	0.34	1772.50±74.08	2036.55±74.08	0.02
VAT/SAT ratio	0.71	1.07	<0.01	0.39	0.38	0.80
Liver fat HUs	61.88±1.36	54.71±1.53	0.01	62.01±1.87	56.08±1.92	0.03
Total cholesterol mg·dL⁻¹	197.94±9.23	217.14±11.63	0.21	192.22±7.65	224.80±7.21	0.01
TGs mg·dL⁻¹	114.28±10.83	159.47±26.06	0.01	120.05±14.24	146.58±13.42	0.20
HyperTGs	22.22	66.66	0.01	17.64	47.37	0.06

Data are expressed as mean±se or %, unless otherwise stated. VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue. HUs: Hounsfield units; TGs: triglycerides; HyperTGs: serum triglyceride levels ≥150 mg·dL⁻¹ or use of lipid-lowering medication.^#: controlled for body mass index.